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Chronic hepatosplenic suppurative brucellosis (CHSB) is a local reactivation of a previous brucellosis,
coursing with an immunoglobulin G (IgG) and IgA secondary immunological response. The observation of two
cases of CHSB with an apparent IgM response gave rise to a detailed serological study of three of our patients.
We studied the first sample from all three patients and successive samples from two of them. In cases 1 and
2, we found samples with positive IgM lateral flow and IgM enzyme-linked immunosorbent assay results
concomitantly with rheumatoid factor (RF); after absorption with anti-RF serum, these results were rendered
negative. In patients 2 and 3 the diagnosis of brucellosis was delayed, because none of the test results were
initially very significant. However, a clear seroconversion of IgG antibodies was observed in subsequent
months; titers of the Brucellacapt and Coombs tests increased in similar ways, although Brucellacapt de-
creased more rapidly than Coombs, which persisted at high titers for years. In patient 3 a relapse was observed
in the fourth year of follow-up, detected by Coombs and also by IgG lateral flow and counterimmunoelectro-
phoresis (CIEP), although not by the rose bengal, agglutination, or Brucellacapt tests. Serological changes in
CHSB may sometimes be mild and are detected mainly by the Coombs test. Brucellacapt does not offer
additional information, although IgG lateral flow and CIEP may be of some use. Careful surveillance of titer
changes in the Coombs test is the best marker of infection activity. As the disease progresses, an intense IgG
response may develop and RF sometimes appears, simulating an IgM response.
Chronic hepatosplenic suppurative brucellosis (CHSB) was
first reported many years ago (23). Two recent series provided
a current understanding of this rare focal form of the disease
and emphasized that it is in fact a local reactivation of a
previous episode of brucellosis (1, 5).
The diagnosis may be misleading because of the nonspecific
clinical presentation of CHSB and the frequent negativity of
blood and abscess pus cultures (1). Although modern PCR
techniques have proved useful in identifying brucellar antigen
in these pus cultures (6), in many cases the diagnosis is sup-
ported mainly by serological tests.
As CHSB is a reactivated disease, serological changes cor-
responding to a secondary immunological response are usually
observed (1). Despite some controversial opinions (11), we
previously demonstrated that the secondary response in pa-
tients with brucellosis relapse was always of anti-Brucella im-
munoglobulin G (IgG) and IgA, and not IgM, antibodies, as
occurs with other thymus-dependent antigens (2, 12, 19, 25). In
addition, this secondary serological response may be difficult to
detect in some cases, depending on the point in the clinical
course of the disease. Thus, the initial diagnosis of CHSB and
the evaluation of its spontaneous or posttherapy outcome on
the basis of the serological profile of specific antibodies may
prove confusing.
The observation of two of these CHSB cases with an appar-
ent IgM serological response gave rise to a detailed study of
the serological behavior of this unusual disease form in three
of our patients. The concomitant use of classical and recently
incorporated tests for quantifying anti-lipopolysaccharide
(LPS) antibodies (the rose bengal [RB], agglutination [SAT],
Coombs, and Brucellacapt tests) and of IgM and IgG lateral
flow tests and counterimmunoelectrophoresis (CIEP) to detect
anti-water-soluble cytosolic protein antibodies enabled us to
identify some peculiar and interesting findings for this reacti-
vated brucellosis. These findings may contribute to a better
understanding of both the specific role of each serological test
in the diagnosis of the disease and how to interpret the pres-
ence of antibodies with various levels of affinity.
Patient 1. Patient 1 was a 39-year-old man seen on 20 Sep-
tember 2000 in the Clı´nica Universitaria (Pamplona, Spain) for
a left pleural effusion, diagnosed 1 month previously in another
medical center. Computed tomography (CT) examination
showed pleural collection (size, 6 by 8 cm) and a calcium
density with hypodensity around 4 cm in the spleen. The pa-
tient’s work involved cleaning up sheep stalls, and he referred
to a previous episode of fever, asthenia, arthralgias, and weak-
ness in 1990; however, suspected brucellosis could not be con-
firmed with serological tests at that time, and clinical findings
disappeared in 6 months without any specific antibiotic ther-
apy. Afterward, he lived for years in an area in which brucel-
losis was not endemic. In March 2000, he once again developed
fever, arthralgias, and lumbar pain, and acute brucellosis was
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diagnosed; rifampin and doxycycline were given for 6 weeks,
and he became well until a relapse in May 2000. A new ther-
apeutic schedule of doxycycline and streptomycin was admin-
istered but with only partial improvement. In July 2000, clinical
findings reappeared, along with intense left-side pain second-
ary to pleural effusion. Under prolonged doxycycline-rifampin
therapy, he remained free of fever when evaluated in the
Clinica Universitaria. At this time blood cultures were nega-
tive, but Brucella melitensis biogroup 3 was isolated from a
pleural empyema. It is noteworthy that among the analytical
results was the finding of 175 IU/ml of rheumatoid factor (RF),
quantified by means of nephelometry (Beckman Image).
Patient 2. Patient 2 was a 67-year-old man with previous
brucellosis, cured 40 years previously, but no further history of
brucellosis-related complaints. He had not been exposed to
any risk factor for brucellosis for years. He was admitted to
the Hospital de Bellvitge (Barcelona, Spain) on 27 May 1999
because of high fever with chills and deteriorated general con-
dition for 15 days. At admission, hypotension, peripheral hy-
poperfusion findings, scleral icterus, and painful hepatic en-
largement of 3 to 4 cm were observed. The white blood cell
count was 2,800/mm3, platelets were 49,000/mm3, aspartate
aminotransferase/alanine aminotransferase was 3.9/3.9 kat/
liter, and conjugated bilirubin/total bilirubin was 53/66 mol/
liter. Blood cultures were negative. The RB test was negative,
and SAT was positive at 1:40 and was considered a residual
effect of previous brucellosis. Septicemia of an unknown
source was diagnosed, and initial empirical combination treat-
ment of amoxicillin-clavulanate plus gentamicin, as well as
further doxycycline, was given. Over subsequent days, digestive
bleeding appeared secondary to stress ulcus, and a gastrectomy
was performed. An abdominal CT showed a calcium density in
the liver without other pathological findings. Ten weeks after
admission, fever reappeared, seroconversion was observed,
and brucellosis was diagnosed (August 1999). Oral doxycycline
at 100 mg/12 h plus intramuscular gentamicin at 240 mg/day for
the first 15 days and then oral rifampin at 900 mg/day there-
after were given. In a new CT (19 August 1999), hypodensity
next to the calcium image was apparent and a reactivation of
latent brucellar liver granuloma was diagnosed, presumably
related to the previous brucellosis. Since fever persisted with
antibiotic therapy for 70 days, resection of the abscess was
performed (October 1999); a pus culture was negative. The
fever disappeared and the general condition was recovered,
while antibiotic therapy was prolonged for 5 months. The out-
come was good and the patient remained cured in subsequent
controls for 4 years.
Patient 3. Patient 3 was a 49-year-old woman who reported
a previous diagnosis of brucellosis more than 20 years earlier
but with no other clinical problems throughout this period. She
remained in an area in which brucellosis was not endemic and
had not been exposed for any risk factor for brucellosis in
recent years. She was admitted in May 1995 to the Hospital de
Bellvitge (Barcelona, Spain) suffering from high fever, chills,
sweating, arthralgias, and weakness for 1 week. At admission,
hepatomegaly (3 cm) and splenomegaly (1 cm) were detected
and there was right-side pain secondary to a pleural effusion.
An abdominal CT showed a calcium density with surrounding
hypodensity in the liver, pus being obtained through punction
aspiration. Blood cultures were negative, and no isolates were
detected in the pus culture. Since the RB test was negative,
brucellosis was initially ruled out and a probable diagnosis of
liver pyogenic abscess was considered. Despite antibiotic ther-
apy with amoxicillin-clavulanate and repeated percutaneous
aspirations, clinical findings persisted for 4 weeks. In June
1995, a repeated RB test became slightly positive, and SAT and
the Coombs test confirmed the diagnosis of reactivated previ-
ous brucellar liver granuloma. Given a doxycycline-streptomy-
cin combination (45 days and 15 days, respectively), the patient
became well. Successive abdominal CT performed over subse-
quent years showed progressive heterogeneous calcified im-
ages, with some hypodensity (6 by 3 cm) of difficult evaluation
(January 2000). Two years later (January 2002), this image
increased slightly in size (7 by 5.5 cm), but she remained
symptom free until January 2004 (more than 8 years after
initial therapy), when fever and upper-right abdominal pain
once again appeared for 2 weeks, along with a smooth subcu-
taneous tumor in this area. CT examination showed a subcu-
taneous extension of liver abscess (February 2004) (Fig. 1). She
underwent percutaneous aspiration of pus (the culture was
again negative) and prolonged antibiotic therapy with doxycy-
cline and rifampin for 5 months, before a surgical hepatic
resection was performed in July 2004. The outcome was good
for the following year.
MATERIALS AND METHODS
Serum samples, antigenic preparations, and serological tests. From patient 1,
the serum sample obtained in the Clinica Universitaria was the only sample
available for serological studies; from the other two patents, 10 and 12 successive
samples were obtained during follow-up periods of 4 and 9 years, respectively.
The RB test was performed with antigen produced at the Central Veterinary
Laboratory (Weybridge, Surrey, United Kingdom). Positive sera were diluted in
saline to give dilutions ranging from 1:1 to 1:512, and the RB test was repeated
with these dilutions. SAT was performed in ordinary 96-well microtitration-type
polystyrene plates by making twofold serial dilutions (i) in 50 l of phosphate-
buffered saline (PBS), pH 7.2, with the addition of an equal volume to each 1:80
dilution of the milk ring test antigen (Central Veterinary Laboratory) (8, 12) and
(ii) in 50 l of the dilution buffer at pH 5.0 used in the Brucellacapt (Vircell
Company, Santa Fe, Granada, Spain) test, with the addition of an equal volume
of the cell suspension included in the Brucellacapt kit. It should be noted that we
never used the U-bottomed microtiter plates coated with anti-total human im-
munoglobulin included in the Brucellacapt kit. The Coombs test was performed
by the method described by Otero et al. (17) using anti-IgG human immuno-
globulins (Operon, Zaragoza) diluted 1:1,000 in PBS. The CIEP test, using
water-soluble proteins, was performed as described previously (7). The cytosolic
fraction was obtained from rough B. melitensis 115 by the method previously
described (15). The indirect enzyme-linked immunosorbent assay (ELISA) for
the detection of IgM antibodies and the immunochromatographic lateral flow
assay for the detection of IgM and IgG (IgM flow and IgG flow) were performed
by the methods described by Ariza et al. (2) and Smits et al. (22).
RESULTS
Table 1 shows the results obtained with the different sero-
logical tests when the first serum samples of the three patients
were examined, while Tables 2 and 3 summarize the results of
the evolution of serological data obtained with serum samples
from patients 2 and 3, respectively.
Anti-IgM antibodies. In patient 1, the IgM lateral flow was
4 and the IgM ELISA titer was 1:800 at the time of diagnosis.
As it showed 175 IU/ml of RF, the serum was absorbed with an
anti-RF serum (ELISA Sorbent; Vircell, Granada, Spain), af-
ter which the IgM lateral flow and IgM ELISA were negative.
Similarly, when the presence of RF was studied in the serum
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samples from patient 2 by using latex particles coated with
human gamma globulin (Biokit, Barcelona, Spain), all sam-
ples with positive IgM flow results agglutinated them but
were negative after absorption with anti-RF serum (ELISA
Sorbent; Vircell, Granada, Spain) (Table 2). Finally, all
serum samples from patient 3 were RF and IgM lateral flow
negative (Table 3).
Anti-LPS IgG antibodies. For patient 1, all tests detecting
anti-LPS antibodies were clearly positive, making the initial
diagnosis easy. The diagnosis of patient 2 was delayed because
the initial titers of SAT and Coombs IgG at admission were
interpreted as a residual sign of the previous brucellosis (Table
1). Likewise, the titers obtained in the SAT at pH 5.0 (Brucel-
lacapt) and IgG lateral flow were insignificant or negative.
However, a serological study of the serum sample taken after
3 months demonstrated clear seroconversion and that the an-
tibiotic administration was unable to avoid the increment of
titers. Moreover, a progressive diminution of titers was ob-
served after surgical resection of the abscess (Table 2). Figure
2 shows the evolution of titers of SAT and Coombs IgG per-
formed at pH 7.2 and 5.0. The results show that before the
surgical resection, the titers of the four tests increased progres-
sively and the titers of the SAT (pH 5.0) and Coombs IgG (pH
7.2) were practically the same. However, after surgical resec-
FIG. 1. (A) CT of the liver, showing a calcium density and slight surrounding hypodensity 1 year after therapy. (B) Abdominal CT 4 years after
therapy, with progressive heterogeneous calcified images and some hypodensity (6 by 3 cm) of difficult evaluation. (C) Increase in the size of this
image (7 by 5.5 cm) 6 years after therapy. (D) CT examination 8 years after therapy, showing a subcutaneous extension of the liver abscess.
TABLE 1. Results of serological tests at admissiona
Patient RF(IU/ml)
Titer obtained with indicated test
CIEP result (no. of
bands/titer)
Lateral flowb
RB
SAT
Coombs IgG
pH 7.2 pH 5.0 IgM IgG
1 175 32 1,280 40,960 40,960 6/128 4* 4
2 Neg Neg 40 160 1,280 Neg Neg 1
3 ND Neg Neg ND ND ND ND ND
a Abbreviations: Neg, negative; ND, not done.
b 1, weak staining; 2, moderate staining; 3, strong staining; 4, very strong staining; *, IgM was initially 4 but became negative after absorption of RF.
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tion the titers of the SAT (pH 5.0) (Brucellacapt) descended
more rapidly than the Coombs IgG (pH 7.2) titers. The per-
sistence of Coombs (pH 7.2) titers of 1:5,120 for 4 years after
admission should be emphasized.
For patient 3, the RB test was negative at admission and,
thus, other serological tests were not performed. Due to the
persistence of clinical findings under amoxicillin-clavulanate
therapy, serological tests were repeated a month later and
seroconversion was detected (RB, positive; SAT, 1:80;
Coombs, 1:640); the patient was then treated with a combina-
tion of doxycycline-streptomycin. The results of serological
tests carried out with the serum sample obtained 3 months
after therapy showed anti-LPS and anti-cytosolic protein IgG
antibodies, although the IgM lateral flow was negative. The
results of these serological tests showed that after 4 years, the
patient had a new antigenic stimulus, even though he did not
show clinical symptoms or signs; in fact, 4 years later (26 April
2000), when the patient was free of brucellosis-related symp-
toms, a significant increase in anti-LPS IgG antibodies was
detected by the Coombs test and the IgG lateral flow assay.
However, no serological changes were shown by the RB, SAT
(pH 7.2), or SAT (pH 5.0) (Brucellacapt) tests, and those
appearing in the abdominal CT were unclear (Fig. 1B). Eight
years later (18 February 2004), a clinical relapse of liver sup-
puration was demonstrated, while titers of the RB, SAT (pH
7.2), and SAT (pH 5.0) (Brucellacapt) tests continued to show
a progressive decrease; only the Coombs test maintained a
notoriously high titer, 1:2,560 (Table 3).
Anti-cytosolic protein antibodies (CIEP). In CIEP with wa-
ter-soluble cytosolic proteins, the three patients developed pre-
cipitation lines. When CIEP was carried out with a whole serum
sample from patient 1, the development of six precipitation lines
was shown, with a titer up to 1:128. For patient 2, CIEP became
positive after 3 months. As with the titers of serological tests
detecting anti-LPS antibodies, the number of precipitation lines
and the CIEP titer increased progressively before descending
TABLE 2. Serological results over time from patient 2a
Time of serum sample RF(IU/ml)
Titer obtained with indicated test
CIEP result
(no. of bands/
titer)
Lateral flowc
RB
SATb Coombs IgG
pH 7.2 pH 5.0 pH 7.2 pH 5.0 IgG IgM
25 May 1999 Neg Neg 40 160 1,280 2,560 Neg 1 Neg
7 August 1999 132 4 160 2,560 2,560 5,120 3/8 2 2
Antibiotic therapy
19 August 1999 2 8 320 5,120 10,240 10,240 4/32 2 2
10 September 1999 2 16 640 40,960 40,960 40,960 5/64 3 3
18 October 1999 2 16 1,280 81,920 81,920 81,920 5/64 3 3
Liver resection (2 November 1999)
6 mo Neg 8 320 5,120 20,480 40,960 2/16 ND ND
1 yr Neg 4 80 640 10,240 10,240 2/8 1 Neg
2 yr Neg 4 80 320 5,120 10,240 2/4 ND ND
3 yr Neg 2 40 320 5,120 10,240 1/1 Neg Neg
4 yr Neg 2 40 320 5,120 10,240 1/1 ND ND
a Abbreviations: Neg, negative; ND, not done.
b The SAT at pH 7.2 was done with milk ring test antigen (PBS); the SAT at pH 5.0 was done with Brucellacapt antigen (Vircell).
c 1, weak staining; 2, moderate staining; 3, strong staining.
TABLE 3. Serological results over time from patient 3a
Time of serum sample RF
Titer obtained with indicated test
CIEP result
(no. of
bands/titer)
Lateral flow c
RB
SAT b Coombs IgG
pH 7.2 pH 5.0 pH 7.2 pH 5.0 IgM IgG
27 May 1995 ND Neg ND ND ND ND ND ND ND
26 June 1995 ND 2 80 ND 640 ND ND ND ND
Specific antibiotic therapy (45 days)
3 mo Neg 16 160 320 2,560 2,560 2/8 Neg 3–4
6 mo Neg 16 80 160 2,560 2,560 2/4 Neg 2
1 yr Neg 8 80 160 1,280 1,280 2/2 Neg 2
2 yr Neg 4 20 80 1,280 1,280 2/2 Neg 1
4 yr Neg 2 40 80 5,120 5,120 2/4 Neg 3–4
6 yr Neg Neg 20 40 2,560 5,120 2/2 Neg 2
8 yr Neg Neg 20 40 2,560 2,560 2/2 Neg 1–2
February 2004 (clinical relapse;
antibiotic therapy, 6 mo)
April 2004 (therapy, 2 mo) Neg Neg 20 40 2,560 1,280 2/4 Neg 1–2
July 2004 (liver resection)
November 2004 Neg Neg 20 40 1,280 1,280 2/4 Neg 1–2
a Abbreviations: Neg, negative; ND, not done.
b The SAT at pH 7.2 was done with milk ring test antigen (PBS); the SAT at pH 5.0 was done with Brucellacapt antigen (Vircell).
c 1, weak staining; 2, moderate staining; 3, strong staining; 4, very strong staining.
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after surgical resection. For patient 3, the results of CIEP carried
out with the serum corresponding to 3 months were positive (two
precipitation lines and a titer of 1:4); moreover, it should be noted
that CIEP remained positive 8 years later.
DISCUSSION
Detailed serological study of our patients has once again
demonstrated that reactivation of CHSB is associated mainly
with a secondary IgG serological response. These results con-
firm our previous findings regarding secondary serological
changes in brucellosis relapse (2, 12, 19), which did not show
an increase in IgM antibodies, as in the case of other thymus-
dependent antigen responses (25).
The IgM lateral flow assay has been reported to be a very
specific and sensitive test for the diagnosis of human brucel-
losis (22). It is known that IgM antibodies decrease after the
first few months and therefore are not observed in some pa-
tients with prolonged disease (2, 9). However, their specificity
is currently considered to be very high, close to 100%, and no
identified false-positive results have been described. Thus, the
finding of positive IgM lateral flow and IgM ELISA titers with
two of our patients was surprising and suggested the emer-
gence of a secondary response with an increase in IgM anti-
bodies; it was this finding that motivated us to reexamine our
data.
Patient 1 had 175 IU/ml of RF. Nowadays, RF is recognized
as presenting one of the most serious problems in IgM testing
(13), provided that the RFs are anti-IgG IgM antibodies. Sev-
eral authors have reported the presence of RF in patients with
brucellosis (3, 10, 14), but the potential interference of RF in
diagnostic tests based on the detection of IgM antibodies to
Brucella has not been evaluated. The concomitant observation
of positive RF and anti-IgM tests led us to suspect a relation-
ship between these two findings. This hypothesis was con-
firmed, given that all positive IgM lateral flow and IgM ELISA
samples were rendered negative when studies were repeated
after absorption of the samples with anti-RF serum. The pres-
ence of false-positive results may be of relevance for some
patients with CHSB who report an acute clinical presentation
(1), where an apparent IgM response may make it difficult to
diagnose a reactivation of previous brucellosis. Thus, the elim-
ination of RF by absorption should be performed in a routine
way before testing of sera for the presence of IgM-type anti-
bodies.
Moreover, the frequency of positive RF in patients with
brucellosis seems to be low overall but prevails in patients with
focal and prolonged disease, in whom an intensive antigenic
stimulation could be assumed. Thus, in a large series of patients,
Mousa et al. (14) reported positive RF in 8.8% of 169 patients
with osteoarticular disease but in only 0.2% of 283 patients with-
out these complications. These results suggest that if IgM anti-
bodies are found in patients with supposed brucellosis relapse
or reactivation, or in patients with focal or prolonged disease,
the possibility of a positive RF as the cause of false-positive
results should be ruled out.
Patients with CHSB often have negative pus cultures and usu-
ally show negative blood cultures, despite some of them present-
ing with acute clinical symptoms and significant systemic reper-
cussions (1). This surprising observation may illustrate the nature
of this clinical form of brucellosis, which is in fact a local reacti-
vation of a previous calcified granuloma. This is characterized by
the presence of a low local bacterial inoculum, which probably
produces this general repercussion through late hypersensitivity
mechanisms. In fact, the systematic presence of small quantities
of microorganisms has been demonstrated by Colmenero et al.
using PCR techniques with pus and calcified granuloma samples,
the results showing negative cultures (5, 6). Centrifugation-shell
vial culture may also be a successful method for detecting bacteria
in these cases (20). In this context, diagnosis must be based on
serological results if PCR techniques or shell vial cultures are not
available.
The secondary serological response detected by classical
anti-LPS tests, such as the RB test, SAT, and the Coombs test,
may provide confusing results at the time of clinical diagnosis
for some patients. This occurred in two of our cases and led to
a delay in the diagnosis of brucellosis. It should be noted that
for one of these cases (patient 2), in which we were able to
extend the study of this initial sample using various classical or
modern serological tests, such as Brucellacapt, IgG lateral
flow, and CIEP, no additional contribution to the diagnosis was
obtained.
Some specific issues regarding the comparison of the Bru-
cellacapt test with SAT and Coombs test results should be
considered. The Brucellacapt test has recently been developed
by the Vircell Company (Santa Fe, Granada, Spain) as an
immunocapture-agglutination test; it uses dilution buffer at pH
5.0, a cell suspension of Brucella in buffer, also at pH 5.0, and
U-bottomed microtiter plates coated with anti-total human
immunoglobulin, included in the Brucellacapt kit. Reported
results have been very promising and are closely related to
those of the Coombs test; however, it has been suggested that
they may become a better marker of disease activity (4, 16).
In the present study we performed SAT and the Coombs test
at pH 5.0 with an antigenic suspension of Brucellacapt but
FIG. 2. SAT (at pH 7.2 and pH 5.0 [Brucellacapt]) and Coombs (at
pH 7.2 and pH 5.0) titers over time from patient 2. Note the rapid
decrease in Brucellacapt titers in contrast to the persistence of those of
the Coombs test.
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using ordinary microtitration-type polystyrene plates, because
it has been demonstrated in our laboratory that results of the
Brucellacapt test with the U-bottomed microtiter plates coated
with anti-total human immunoglobulin included in the Brucel-
lacapt kit were identical to those obtained with ordinary mi-
crotitration-type polystyrene plates (J. L. del Pozo, M. Rubio,
and R. Dı´az, Abstr. X Congr. Nacional Soc. Espan˜ola Enfer-
medades Infecc. Microbiol. Clin. [SEIMC], abstr. 599, 2002).
For patient 2 (Fig. 2), the titers of Brucellacapt (SAT at pH
5.0) and Coombs (pH 7.2) were similar in the third, fourth, and
fifth samples obtained during the 2 months of antibiotic ther-
apy but prior to liver resection; in contrast, the subsequent titer
profile decreased more rapidly with Brucellacapt (SAT at pH
5.0) than with the Coombs (pH 7.2) test. The persistence of
high Coombs (pH 7.2) and Coombs (pH 5.0) titers (1:5,120) 4
years later, despite the patient being cured, should be noted;
this may be a residual effect following an intense and pro-
longed secondary immunological stimulation. Although the ti-
ters of the Coombs test performed at pH 5.0 and at pH 7.2
were identical, the titers of SAT at pH 5.0, performed with the
antigenic suspension included in the Brucellacapt kit, were
several times higher than those of SAT (pH 7.2) performed
with ring milk test antigen.
There are two possible explanations for this fact. It is known
that pH modifies antibody affinity (18), and it has been dem-
onstrated that the agglutinating ability of IgG and IgA anti-
bodies increases at acidic pH (21). The rapid fall of SAT (pH
5.0) titers obtained with the Brucellacapt antigen, with respect
to the decrease in antigenic stimulation following antibiotic
therapy, suggests that the agglutinating activity is due to high-
affinity antibodies. However, it has also been demonstrated
that LPS of Brucella contains acyl chains that are not present in
other gram-negative bacteria, with the exception of Ochrobac-
trum spp., resulting in an increase in its hydrophobic charac-
teristics (24) and in a conformation that may hide immuno-
dominant epitopes of the O chain. Therefore, the hypothesis
that acidic pH, increasing the ionic forces, may carry with it a
decrease in the hydrophobic characteristics of LPS and then a
separation of the chains and an exposition of unrecognizable
epitopes at neutral pH cannot be ruled out.
Analysis of the serological profile of patient 3 showed that
evaluation during late clinical follow-ups of patients after ther-
apy may be misleading. This patient, undergoing percutaneous
abscess drainage and antibiotic therapy, suffered from a clini-
cal relapse 8 years later. However, in addition to radiological
findings, serological changes indicative of further clinical re-
lapse were detected 4 years earlier by the Coombs test, though
no such changes were observed in the RB test, SAT at pH 7.2,
or SAT at pH 5.0 (Brucellacapt). It should be noted that this
relapse was also detected by the IgG lateral flow assay and
CIEP, along with the changes in the Coombs test.
The results of our study indicate that in some patients with
CHSB, serological changes occurring due to the reactivation of
the infection, either at the beginning of the disease or subse-
quently, during follow-up, may be mild and include low-affinity
antibodies or small quantities of high-affinity antibodies, de-
tected mainly by the Coombs test. Brucellacapt and other anti-
LPS tests do not offer any additional information in this con-
text, but the IgG lateral flow assay and CIEP may be of some
use. Since high Coombs test titers may persist for a long time
in cured patients, careful surveillance of titer changes in this
test in paired samples would seem to be the best marker of
infection activity. As the disease progresses, an intense IgG
secondary response may develop and RF sometimes appears,
simulating an IgM response.
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